Structure and dynamics of the somatostatin receptor 3‐ligand binding in the presence of lipids examined using computational structural biology methods-Reference-Cited by-同舟云学术

Structure and dynamics of the somatostatin receptor 3‐ligand binding in the presence of lipids examined using computational structural biology methods

Published:2021-10-25 Issue:3 Volume:90 Page:704-719
ISSN:0887-3585
Container-title:Proteins: Structure, Function, and Bioinformatics
language:en
Short-container-title:Proteins

Author:

Nagarajan Santhosh Kumar¹^ORCID,Babu Sathya¹,Devaraju Panneer²,Sohn Honglae³⁴,Madhavan Thirumurthy¹^ORCID

Affiliation:

1. Computational Biology Lab, Department of Genetic Engineering School of Bioengineering, SRM Institute of Science and Technology Chennai India

2. Division of Microbiology and Molecular Biology Vector Control Research Centre, Indian Council of Medical Research Pondicherry India

3. Department of Chemistry Chosun University Gwangju South Korea

4. Department of Carbon Materials Chosun University Gwangju South Korea

Funder

Ministry of Science and ICT, South Korea

National Research Foundation of Korea

Publisher

Wiley

Subject

Molecular Biology,Biochemistry,Structural Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prot.26267

Reference67 articles.

1. Structure versus function—The impact of computational methods on the discovery of specific GPCR–ligands

2. GPCR crystal structures: Medicinal chemistry in the pocket

3. Integrating structural and mutagenesis data to elucidate GPCR ligand binding

4. How Ligands Illuminate GPCR Molecular Pharmacology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations;Computational and Structural Biotechnology Journal;2024-12

2. Computational drug repositioning for IL6 triggered JAK3 in rheumatoid arthritis using FDA database;Molecular Diversity;2024-08-14

3. Computational drug repositioning for IL6 triggered JAK3 in Rheumatoid Arthritis using FDA database;2024-01-02